{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T01:40:22Z","timestamp":1760751622088,"version":"build-2065373602"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Hospital Organization"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-19452-2","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:40:27Z","timestamp":1760362827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urine phospholipid profiling in patients with rheumatoid arthritis and nontuberculous mycobacterial pulmonary disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Hiroshi","family":"Furukawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shomi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misuzu","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Ihata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuminori","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitomo","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Migita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Tohma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"issue":"5","key":"19452_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3109\/s10165-011-0577-6","volume":"22","author":"S Mori","year":"2012","unstructured":"Mori, S. et al. Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: A retrospective multicenter study in Japan. Mod. Rheumatol. 22(5), 727\u2013737 (2012).","journal-title":"Mod. Rheumatol."},{"issue":"4","key":"19452_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith, D. E. et al. An official ATS\/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care. Med. 175(4), 367\u2013416 (2007).","journal-title":"Am. J. Respir. Crit. Care. Med."},{"issue":"5","key":"19452_CR3","first-page":"547","volume":"86","author":"K Morimoto","year":"2011","unstructured":"Morimoto, K. et al. Nontuberculous mycobacteriosis mortality in Japan. Kekkaku 86(5), 547\u2013552 (2011).","journal-title":"Kekkaku"},{"issue":"9","key":"19452_CR4","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1086\/383317","volume":"38","author":"RS Wallis","year":"2004","unstructured":"Wallis, R. S., Broder, M. S., Wong, J. Y., Hanson, M. E. & Beenhouwer, D. O. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin. Infect. Dis. 38(9), 1261\u20131265 (2004).","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"19452_CR5","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1086\/424455","volume":"39","author":"RS Wallis","year":"2004","unstructured":"Wallis, R. S., Broder, M., Wong, J. & Beenhouwer, D. Granulomatous infections due to tumor necrosis factor blockade: Correction. Clin. Infect. Dis. 39(8), 1254\u20131255 (2004).","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"19452_CR6","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1136\/thoraxjnl-2014-206470","volume":"70","author":"SK Brode","year":"2015","unstructured":"Brode, S. K. et al. Increased risk of mycobacterial infections associated with anti-rheumatic medications. Thorax 70(7), 677\u2013682 (2015).","journal-title":"Thorax"},{"issue":"13","key":"19452_CR7","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1056\/NEJM198909283211304","volume":"321","author":"DS Prince","year":"1989","unstructured":"Prince, D. S. et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N. Engl. J. Med. 321(13), 863\u2013868 (1989).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"19452_CR8","first-page":"1605","volume":"101","author":"JM Reich","year":"1992","unstructured":"Reich, J. M. & Johnson, R. E. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. Lady Windermere syndr. Chest 101(6), 1605\u20131609 (1992).","journal-title":"Lady Windermere syndr. Chest"},{"issue":"7","key":"19452_CR9","first-page":"597","volume":"2","author":"Y Obayashi","year":"1998","unstructured":"Obayashi, Y. et al. Clinical features of non-tuberculous mycobacterial disease: comparisons between smear-positive and smear-negative cases, and between Mycobacterium avium and Mycobacterium intracellulare. Int. J. Tuberc. Lung Dis. 2(7), 597\u2013602 (1998).","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"1","key":"19452_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1378\/chest.105.1.49","volume":"105","author":"SJ Swensen","year":"1994","unstructured":"Swensen, S. J., Hartman, T. E. & Williams, D. E. Computed tomographic diagnosis of Mycobacterium avium-intracellulare complex in patients with bronchiectasis. Chest 105(1), 49\u201352 (1994).","journal-title":"Chest"},{"issue":"1","key":"19452_CR11","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1148\/radiol.2351040371","volume":"235","author":"WJ Koh","year":"2005","unstructured":"Koh, W. J. et al. Bilateral bronchiectasis and bronchiolitis at thin-section CT: Diagnostic implications in nontuberculous mycobacterial pulmonary infection. Radiology 235(1), 282\u2013288 (2005).","journal-title":"Radiology"},{"issue":"18","key":"19452_CR12","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMra012519","volume":"346","author":"AF Barker","year":"2002","unstructured":"Barker, A. F. Bronchiectasis. N. Engl. J. Med. 346(18), 1383\u20131393 (2002).","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"19452_CR13","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.rmed.2012.07.006","volume":"106","author":"S Mori","year":"2012","unstructured":"Mori, S., Koga, Y. & Sugimoto, M. Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis. Respir. Med. 106(11), 1591\u20131599 (2012).","journal-title":"Respir. Med."},{"issue":"7","key":"19452_CR14","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1093\/rheumatology\/kew025","volume":"55","author":"S Oka","year":"2016","unstructured":"Oka, S. et al. Association of human leukocyte antigen alleles with chronic lung diseases in rheumatoid arthritis. Rheumatology 55(7), 1301\u20131307 (2016).","journal-title":"Rheumatology"},{"issue":"273","key":"19452_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s13075-015-0787-y","volume":"17","author":"W Hirose","year":"2015","unstructured":"Hirose, W. et al. Diagnostic performance of measuring antibodies to the glycopeptidolipid core antigen specific to Mycobacterium avium complex in patients with rheumatoid arthritis: results from a cross-sectional observational study. Arthritis Res. Ther. 17(273), 273 (2015).","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"19452_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/14397595.2017.1336866","volume":"28","author":"K Iwata","year":"2018","unstructured":"Iwata, K. et al. Biomarker for nontuberculous mycobacterial pulmonary disease in patients with rheumatoid arthritis: Anti-glycopeptidolipid core antigen immunoglobulin a antibodies. Mod. Rheumatol. 28(2), 271\u2013275 (2018).","journal-title":"Mod. Rheumatol."},{"issue":"7","key":"19452_CR17","doi-asserted-by":"publisher","first-page":"e40459","DOI":"10.1371\/journal.pone.0040459","volume":"7","author":"S Nishiumi","year":"2012","unstructured":"Nishiumi, S. et al. A novel serum metabolomics-based diagnostic approach for colorectal cancer. PLoS ONE 7(7), e40459 (2012).","journal-title":"PLoS ONE"},{"issue":"3","key":"19452_CR18","doi-asserted-by":"publisher","first-page":"e0010422","DOI":"10.1128\/msphere.00104-22","volume":"7","author":"P Breen","year":"2022","unstructured":"Breen, P., Zimbric, M., Opron, K. & Caverly, L. J. Sputum metabolites associated with nontuberculous mycobacterial infection in cystic fibrosis. mSphere 7(3), e0010422 (2022).","journal-title":"mSphere"},{"issue":"1","key":"19452_CR19","doi-asserted-by":"publisher","first-page":"15312","DOI":"10.1038\/s41598-024-66113-x","volume":"14","author":"NK Anh","year":"2024","unstructured":"Anh, N. K. et al. Discovery of urinary biosignatures for tuberculosis and nontuberculous mycobacteria classification using metabolomics and machine learning. Sci. Rep. 14(1), 15312 (2024).","journal-title":"Sci. Rep."},{"issue":"11","key":"19452_CR20","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00011-024-01943-z","volume":"73","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. Olink proteomics and lipidomics analysis of serum from patients infected with non-tuberculous mycobacteria and mycobacterium tuberculosis. Inflamm. Res. 73(11), 1945\u20131960 (2024).","journal-title":"Inflamm. Res."},{"issue":"3","key":"19452_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett, F. C. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31(3), 315\u2013324 (1988).","journal-title":"Arthritis Rheum."},{"issue":"9","key":"19452_CR22","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D. et al. 2010 rheumatoid arthritis classification criteria: An American college of rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum. 62(9), 2569\u20132581 (2010).","journal-title":"Arthritis Rheum."},{"issue":"29","key":"19452_CR23","doi-asserted-by":"publisher","first-page":"12054","DOI":"10.1074\/jbc.M117.790568","volume":"292","author":"H Shindou","year":"2017","unstructured":"Shindou, H. et al. Docosahexaenoic acid preserves visual function by maintaining correct disc morphology in retinal photoreceptor cells. J. Biol. Chem. 292(29), 12054\u201312064 (2017).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"19452_CR24","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1038\/s41467-022-30061-9","volume":"13","author":"K Kanemaru","year":"2022","unstructured":"Kanemaru, K. et al. Plasma membrane phosphatidylinositol (4,5)-bisphosphate is critical for determination of epithelial characteristics. Nat. Commun. 13(1), 2347 (2022).","journal-title":"Nat. Commun."},{"issue":"8","key":"19452_CR25","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/o59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37(8), 911\u2013917 (1959).","journal-title":"Can. J. Biochem. Physiol."},{"issue":"W1","key":"19452_CR26","doi-asserted-by":"publisher","first-page":"W398","DOI":"10.1093\/nar\/gkae253","volume":"52","author":"Z Pang","year":"2024","unstructured":"Pang, Z. et al. MetaboAnalyst 6.0: Towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 52(W1), W398\u2013W406 (2024).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"19452_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13098-025-01780-y","volume":"17","author":"B Zhang","year":"2025","unstructured":"Zhang, B. et al. Serum metabolic profiling in diabetic kidney disease patients using ultra-high performance liquid chromatography-tandem mass spectrometry. Diabetol. Metab. Syndr. 17(1), 197 (2025).","journal-title":"Diabetol. Metab. Syndr."},{"issue":"4","key":"19452_CR28","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3390\/cells9040827","volume":"9","author":"R Coras","year":"2020","unstructured":"Coras, R., Murillo-Saich, J. D. & Guma, M. Circulating pro- and anti-inflammatory metabolites and its potential role in rheumatoid arthritis pathogenesis. Cells 9(4), 827 (2020).","journal-title":"Cells"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19452-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19452-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19452-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T01:02:36Z","timestamp":1760749356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19452-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19452"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19452-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HF has the following conflicts of interest: the Takeda Science Foundation, backed by an endowment from the Takeda Pharmaceutical Company; the Japan Research Foundation for Clinical Pharmacology, associated with Daiichi Sankyo Company Limited; The Daiwa Securities Health Foundation was established by Daiwa Securities Group Inc., and the Nakatomi Foundation, established by the Hisamitsu Pharmaceutical Co. The Mitsui Sumitomo Insurance Welfare Foundation was established by the Mitsui Sumitomo Insurance Co., Ltd. HF received honoraria from the Daiichi Sankyo Company Limited; Ajinomoto Co., Inc.; Dainippon Sumitomo Pharma Co., Ltd.; Takeda Pharmaceutical Company; Pfizer Japan Inc.; Ayumi Pharmaceutical Corporation, and Luminex Japan Corporation Ltd. HF was supported by research grants from Bristol-Myers Squibb Co. ST was supported by research grants from the following pharmaceutical companies: Astellas Pharma Inc.; Abbott Japan Co., Ltd.; Eisai Co., Ltd.; Chugai Pharmaceutical Co., Ltd.; Merck, Sharp and Dohme Inc.; Mitsubishi Tanabe Pharma Corporation; Takeda Pharmaceutical Company Limited; Pfizer Japan Inc.; and Teijin Pharma Limited. ST received honoraria from Astellas Pharma Inc.; Asahi Kasei Pharma Corporation; Chugai Pharmaceutical Co., Ltd.; AbbVie GK.; Mitsubishi Tanabe Pharma Corporation; Ono Pharmaceutical Co., Ltd.; and Pfizer Japan Inc. The other authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was read and endorsed by the National Hospital Organization Central Institutional Review Board and the Research Ethics Committee of Fukushima Medical University School of Medicine. Informed written consent was provided by every study participant. This study was performed according to the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"35694"}}